VITAL phase 2 study: Upfront 5‐fluorouracil, mitomycin‐C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09‐02)

AIM: VITAL, a phase II single‐arm study, aimed to evaluate efficacy and safety of panitumumab addition to 5‐fluorouracil (5‐FU), mitomycin‐C (MMC) and radiotherapy (RT) in patients with localized squamous cell carcinoma of the anal canal (SCCAC). METHODS: Adult, treatment‐naïve SCCAC patients (Stage...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Med
Päätekijät: Feliu, Jaime, Garcia‐Carbonero, Rocio, Capdevila, Jaume, Guasch, Inmaculada, Alonso‐Orduna, Vicente, Lopez, Carlos, Garcia‐Alfonso, Pilar, Castanon, Carmen, Sevilla, Isabel, Cerezo, Laura, Conill, Carles, Quintana‐Angel, Begona, Sanchez, Maria E., Ghanem, Ismael, Martin‐Richard, Marta, Lopez‐Gomez, Miriam, Leon, Ana, Caro, Monica, Fernandez, Teresa, Maurel, Joan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2019
Aiheet:
Clinical Cancer Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6997048/
https://ncbi.nlm.nih.gov/pubmed/31851776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2722
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia